IRVINE, CA – CG Oncology, Inc. (CGON), a biotechnology firm specializing in biological products with a market capitalization of $2.06 billion, announced on Thursday, January 9, 2025, that it has ...
Carlyle Group’s (CG) compensation costs are competitive when compared to other players in the alternative asset management industry. Over the past couple of years, Carlyle Group has spent an average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results